Evidence map›Paper›PMID 38990012›Full record

ArticleAntimicrobial agents and chemotherapy2024

Jacob Strahilevitz, Yair Motro, Violeta Temper, Diana Merezhko, Oshrat Ayalon, Yehonatan Bar Moshe, Margaret M C Lam, Kathryn E Holt, Jacob Moran-Gilad

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Advances in CRISPR-Cas for Diagnosis and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  3. Harnessing interpretable deep learning to predict resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Proteogenomic analysis demonstrates increasedAntimicrobial agents and chemotherapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacob StrahilevitzDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel.
Yair MotroDepartment of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Violeta TemperDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel.
Diana MerezhkoDepartment of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Oshrat AyalonDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel.
Yehonatan Bar MosheDepartment of Radiology, Hadassah-Hebrew University, Jerusalem, Israel.
Margaret M C LamDepartment of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
Kathryn E HoltDepartment of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0003-3949-2471
Jacob Moran-GiladDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel.ORCID 0000-0001-9134-050X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-carbapenemase-producing carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCarbapenemsKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsPorinsBacteremiabeta-LactamasesGenome, BacterialHumansMalePhylogenyPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsOmpK36 protein, Klebsiella pneumoniaePorinscarbapenemin vivoKlebsiellaporin lossresistanceselection

Identifiers

PMID38990012
PMCPMC11304683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.